PrEP (pre-exposure prophylaxis) is a new HIV prevention intervention. PrEP Watch is a clearinghouse for PrEP data, additional research, cost, access and advocacy efforts across the globe.
Communities across the globe are at varying stages of implementation of daily oral PrEP. The US is the only country in which TDF/FTC is approved for use as oral PrEP, but access is expanding globally. In some places, including the US, there is growing uptake; in others, there access is limited to pilot projects. Other countries are not yet exploring implementation. Learn more about access and advocacy below.
Daily oral PrEP involves drugs that are also used in HIV treatment. This means the strategy may only be available via off-label use in some places. Much work is needed to see innovative, impactful introduction.